caption stringlengths 0 3.92k | molecule stringlengths 1 914 | properties listlengths 1 113 | additional_data dict |
|---|---|---|---|
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts barth syndrome and aging. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts diabetic heart disease, non-alcoholic fatty liver disease, and tangier disease. | CCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Aging",
"Cholesterol translocation",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Apoptosis"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts aging and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, tangier disease, and barth syndrome. | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Aging",
"Cholesterol translocation",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Tangier disease",
"Barth syndrome",
"Proton trap for oxidative phosphorylation"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient, fat storage, inflammatory, energy storage that impacts atherosclerosis and pancreatitis. The molecule is a energy source that impacts both obesity and cardiovascular disease. The molecule is a membrane stabilizer that affects cancer by impacting both metabolic syndrome and thyroxine treatmen... | CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"nutrient",
"Atherosclerosis",
"Fat storage",
"inflammatory",
"Pancreatitis",
"Energy storage",
"Obesity",
"Energy source",
"Cardiovascular disease",
"Metabolic syndrome",
"Thyroxine treatment",
"Membrane stabilizer",
"Cancer"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a egfr inhibitor. | CC1CC(C)C(S)C(C)C1 | [
"egfr inhibitor"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
It impacts pancreatitis, cardiovascular disease, and thyroxine treatment. The molecule is a nutrient and a fat storage, impacting both atherosclerosis and metabolic syndrome. | CCCCCCCC/C=C\CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC | [
"Pancreatitis",
"Cardiovascular disease",
"Thyroxine treatment",
"Atherosclerosis",
"Metabolic syndrome",
"nutrient",
"Fat storage"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC[C@@H](O)[C@H](O)C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"nutrient"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a apoptosis, a stabilizing cytochrome oxidase, a energy storage, and smooth. The molecule is a food additive that impacts tangier disease, aging, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a surfactant, a cholesterol translocation, and a energy source, and it impacts ... | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Apoptosis",
"Smooth",
"Stabilizing cytochrome oxidase",
"Energy storage",
"Tangier disease",
"Aging",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"food additive",
"surfactant",
"Barth syndrome",
"Cholesterol translocation",
"Energy source",
"Emulsifier",
"Proton trap ... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
It impacts insulin resistance. | CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC[C@H](O)COC(=O)CCCCCCCCCCCCCCC | [
"Insulin resistance"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a cancer treatment. | CCCCN(CCCC)C(=O)c1cc(C)n(-c2ccc(NS(=O)c3ccc(Br)c(Br)c3)cc2C(=O)N2Cc3ccccc3CC2CO)n1 | [
"cancer treatment"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a cholesterol translocation that impacts diabetic heart disease, non-alcoholic fatty liver disease, barth syndrome, and aging. The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts tangier disease. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Aging",
"Cholesterol translocation",
"Apoptosis",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a anti bacterial. | COc1noc2c(F)c3c(cc12)CC1(C(=O)NC(=O)NC1=O)C1C(C)OCCN31 | [
"anti bacterial"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
It belongs to the organic light-emitting device class of molecules. | N#Cc1ccc(-n2c3ccccc3c3cc(-n4c5ccccc5c5ccccc54)ccc32)c(-c2ccc(-n3c4ccccc4c4cc(C#N)ccc43)cc2C#N)c1 | [
"organic light-emitting device"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a protein kinase inhibitor, btk inhibitor, kinase inhibitor, cancer treatment, and inflammation treatment. | C=CC(=O)N1CCCC(c2nn(-c3ccc(Oc4cccc(F)c4F)cc3)c3c(N)n[nH]c(=O)c23)C1 | [
"protein kinase inhibitor",
"btk inhibitor",
"kinase inhibitor",
"inflammation treatment",
"cancer treatment"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a hypoglycemic agent, a insulinotonic, and a insulinase inhibitor, it impacts schizophrenia and is pharmaceutical. | C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@H](O)[C@@H](O)C(O)O[C@@H]3CO)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O | [
"hypoglycemic agent",
"Schizophrenia",
"Pharmaceutical",
"insulinotonic",
"insulinase inhibitor"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is anti microbial, anti psychotic, and anti parasitic. | CC(=O)OC1OC(COC(=O)C(OC(C)C)=C(C)C(C)C)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O | [
"anti microbial",
"anti psychotic",
"anti parasitic"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, aging, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, apoptosis that impacts barth syndrome and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Stabilizing mitochondrial structure",
"Tangier disease",
"Aging",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Diabetic heart disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
It belongs to both the anti oxidant and anti inflammatory classes of molecules. | CN(C)CCNc1nc(NCc2ccco2)c2ncn(C3CCCCO3)c2n1 | [
"anti oxidant",
"anti inflammatory"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts barth syndrome, diabetic heart disease, and tangier disease. The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts aging and non-alcoholic fatty liver disease. | CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Barth syndrome",
"Cholesterol translocation",
"Diabetic heart disease",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Aging",
"Non-alcoholic fatty liver disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts diabetic heart disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts aging, tangier disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Barth syndrome",
"Aging",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Apoptosis",
"Non-alcoholic fatty liver disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a food additive, a apoptosis, and a stabilizing cytochrome oxidase, and it impacts barth syndrome. The molecule is a energy storage, emulsifier, stabilizing mitochondrial structure, membrane stabilizer, and smooth. The molecule is a proton trap for oxidative phosphorylation and a surfactant, impacting b... | CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"food additive",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Energy storage",
"Emulsifier",
"Stabilizing mitochondrial structure",
"Membrane stabilizer",
"Smooth",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"surfactant",
"Diabetic ... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is light-emitting and phosphorescent. | CC#N.CCCCOC(C)=O.Cc1ccccc1 | [
"light-emitting",
"phosphorescent"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient that affects breast cancer by impacting cervical cancer, ulcerative colitis, and atherosclerosis. | CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\CC1OC1CCCCC | [
"Cervical cancer",
"Breast cancer",
"Ulcerative colitis",
"Atherosclerosis",
"nutrient"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts barth syndrome, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, cholesterol translocation that impacts aging and tangier disease. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Aging",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Cholesterol translocation"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
It impacts heart failure, renal cell carcinoma, celiac disease, and diabetes mellitus type 2. The molecule is a energy source that affects breast cancer by impacting both cardiovascular disease and inflammatory bowel disease. | CCCCCC=CCC(O)CCCCCCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | [
"Heart failure",
"Renal cell carcinoma",
"Celiac disease",
"Diabetes mellitus type 2",
"Energy source",
"Breast cancer",
"Cardiovascular disease",
"Inflammatory bowel disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient. | CC(C)C1NC(=O)C(NC(=O)C(Cc2ccc(O)cc2)NC(=O)C2CCCN2C(=O)C2CCC(=O)N2)n2cc(c3ccccc32)CC(C(=O)O)NC(=O)C(CO)NC(=O)C(Cc2ccccc2)NC1=O | [
"nutrient"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
It influences both colorectal cancer and stomach cancer, as well as affecting cardiovascular disease and breast cancer. It impacts alzheimer's disease, parkinson's disease, seizure, and diabetes mellitus. | CCCCC/C=C\C/C=C\CCCCCCCCCCCC(=O)O[C@@H]1COC(=O)CCC/C=C/C[C@@H]2[C@@H](O)[C@H](O)[C@@H](O)[C@H](OP(=O)(O)OC1)[C@H](OP(=O)(O)O)[C@H](O)[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]2O | [
"Cardiovascular disease",
"Colorectal cancer",
"Breast cancer",
"Stomach cancer",
"Alzheimer's Disease",
"Parkinson's disease",
"Seizure",
"Diabetes mellitus"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient, inflammatory, fat storage, energy source that impacts pancreatitis and metabolic syndrome. The molecule is a energy storage that impacts both atherosclerosis and cardiovascular disease. The molecule is a membrane stabilizer belonging to the thyroxine treatment class, known to affect cancer a... | CCC(C)CCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Pancreatitis",
"nutrient",
"inflammatory",
"Fat storage",
"Metabolic syndrome",
"Energy source",
"Atherosclerosis",
"Cardiovascular disease",
"Energy storage",
"Membrane stabilizer",
"Thyroxine treatment",
"Obesity",
"Cancer"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient that impacts alzheimer's disease, non-alcoholic fatty liver disease, parkinson's disease, and diabetes mellitus type 2. | CCCCC/C=C\C[C@H](O)/C=C/C=C\C/C=C\CCCC(=O)O[C@H](CO/C=C/CCCCCCCCCCCCCC)COP(=O)(O)OCCN | [
"Alzheimer's Disease",
"nutrient",
"Non-alcoholic fatty liver disease",
"Parkinson's disease",
"Diabetes mellitus type 2"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a pim kinase inhibitor and belongs to the cancer treatment class of molecules. | Cc1ccnc2c(C(=O)Nc3cnccc3N3CCCC(N)C3)c(N)oc12 | [
"cancer treatment",
"pim kinase inhibitor"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a membrane stabilizer, nutrient, energy storage, inflammatory that impacts obesity and atherosclerosis. The molecule is a energy source, a thyroxine treatment, and a fat storage. It impacts cancer, metabolic syndrome, cardiovascular disease, and pancreatitis. | CCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC | [
"Membrane stabilizer",
"nutrient",
"Energy storage",
"inflammatory",
"Obesity",
"Atherosclerosis",
"Energy source",
"Thyroxine treatment",
"Fat storage",
"Cancer",
"Metabolic syndrome",
"Cardiovascular disease",
"Pancreatitis"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a anti viral and belongs to the anti allergic class of molecules. | CCCCC(=O)Nc1ccc(CC(=O)OCCC)s1 | [
"anti allergic",
"anti viral"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient. | O=C(OC1Cc2cc(O)c(O)cc2OC1c1ccc(O)c(O)c1)c1cc(O)c(=O)c2c(O)c(O)cc(C3Oc4cc(O)cc(O)c4CC3O)c2c1 | [
"nutrient"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a fat storage and nutrient, and it impacts pancreatitis. The molecule is a member of the thyroxine treatment class and affects atherosclerosis, cardiovascular disease, and metabolic syndrome. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC | [
"Fat storage",
"Pancreatitis",
"nutrient",
"Atherosclerosis",
"Thyroxine treatment",
"Cardiovascular disease",
"Metabolic syndrome"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a emulsifier, a apoptosis, and a energy source, and it impacts barth syndrome. The molecule is a surfactant, stabilizing cytochrome oxidase, cholesterol translocation that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a membrane stabilizer, a food additive, a energy stor... | CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Emulsifier",
"Barth syndrome",
"Apoptosis",
"Energy source",
"surfactant",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Smooth",
"Membrane stabilizer",
"food additive",
"Energy storage",
"Aging",
"Nutritional sup... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a anti tumor. | CC(C)c1cnc(NC(=O)Cc2ccc(NC(=O)Cn3nnc(N4CCCC4)n3)cc2)s1 | [
"anti tumor"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts aging and diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Aging",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Barth syndrome",
"Apoptosis",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a cholesterol translocation, a energy storage, and a nutritional supplement, and it impacts diabetic heart disease. The molecule is a membrane stabilizer, energy source, surfactant, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative... | CCC(C)CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C | [
"Cholesterol translocation",
"Energy storage",
"Diabetic heart disease",
"Nutritional supplement",
"Membrane stabilizer",
"Non-alcoholic fatty liver disease",
"Energy source",
"surfactant",
"Stabilizing cytochrome oxidase",
"Smooth",
"Tangier disease",
"Proton trap for oxidative phosphorylatio... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is floral, sweet, and woody. | COc1cc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CCC4C3CC[C@@]3(C)C4CC[C@@H]3[C@H](C)CCC(C)C(C)C)C2)ccc1O | [
"floral",
"sweet",
"woody"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a energy storage, a stabilizing mitochondrial structure, and a food additive, and it impacts aging. The molecule is a nutritional supplement, apoptosis, energy source that impacts non-alcoholic fatty liver disease and barth syndrome. The molecule is a membrane stabilizer, a stabilizing cytochrome oxidas... | CCC(C)CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Energy storage",
"Aging",
"Stabilizing mitochondrial structure",
"food additive",
"Non-alcoholic fatty liver disease",
"Nutritional supplement",
"Barth syndrome",
"Apoptosis",
"Energy source",
"Membrane stabilizer",
"Stabilizing cytochrome oxidase",
"Smooth",
"surfactant",
"Diabetic heart... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a flavoring agent, citrus, metallic, aldehydic, waxy. The molecule is fresh, coumarinic, and moss; additionally, it is amber and tuberose. | CCCCC/C=C1/CCCC1=O | [
"citrus",
"Flavoring agent",
"metallic",
"aldehydic",
"waxy",
"fresh",
"coumarinic",
"moss",
"amber",
"tuberose"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a energy source, membrane stabilizer, nutrient that belongs to the thyroxine treatment class of molecules and impacts both cardiovascular disease and atherosclerosis. The molecule is a energy storage that affects cancer by impacting pancreatitis. The molecule is a inflammatory and a fat storage, impacti... | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCC(C)C | [
"Energy source",
"Cardiovascular disease",
"Thyroxine treatment",
"Membrane stabilizer",
"nutrient",
"Atherosclerosis",
"Pancreatitis",
"Energy storage",
"Cancer",
"Obesity",
"Metabolic syndrome",
"inflammatory",
"Fat storage"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutritional supplement that impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. The molecule is a emulsifier, cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, energy source. The molecule is a surfactant and a energy st... | CCC(C)CCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Nutritional supplement",
"Diabetic heart disease",
"Aging",
"Non-alcoholic fatty liver disease",
"Emulsifier",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Energy source",
"surfactant",
"Tangier disease",
"Barth syndrome",
... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient that impacts alzheimer's disease, diabetes mellitus type 2, non-alcoholic fatty liver disease, and parkinson's disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C=C\C(=O)CCCCC)COP(=O)(O)OCCN | [
"nutrient",
"Alzheimer's Disease",
"Diabetes mellitus type 2",
"Non-alcoholic fatty liver disease",
"Parkinson's disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, apoptosis, proton trap for oxidative phosphorylation that impacts tangier disease and aging. The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts diabetic heart disease, non-alcoholic fatty liver disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC | [
"Tangier disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Aging",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Barth syndrome"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a anti proliferative, a protein kinase inhibitor, and cancer treatment. | CC(C)N1CCC(CC(N)=O)CC1 | [
"cancer treatment",
"anti proliferative",
"protein kinase inhibitor"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a energy storage and a proton trap for oxidative phosphorylation, it impacts tangier disease, and is smooth. The molecule is a apoptosis, emulsifier, stabilizing cytochrome oxidase, membrane stabilizer that impacts aging. The molecule is a food additive, energy source, surfactant, cholesterol translocat... | CCC(C)CCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)CC | [
"Energy storage",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Smooth",
"Apoptosis",
"Emulsifier",
"Stabilizing cytochrome oxidase",
"Membrane stabilizer",
"Aging",
"food additive",
"Energy source",
"surfactant",
"Cholesterol translocation",
"Diabetic heart disease",
... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient, energy storage, emulsifier, energy source. The molecule is a membrane stabilizer and a surfactant, as well as must and musty. | O=C(O)/C=C/CCC(=O)O | [
"nutrient",
"Energy storage",
"Emulsifier",
"Energy source",
"Membrane stabilizer",
"must",
"musty",
"surfactant"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts tangier disease, aging, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Tangier disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Barth syndrome"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient that impacts diabetes mellitus type 2, non-alcoholic fatty liver disease, alzheimer's disease, and parkinson's disease. | CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C[C@H]1C=CC(=O)[C@@H]1/C=C/[C@@H](O)CCCCC)COP(=O)(O)OCCN | [
"Diabetes mellitus type 2",
"Non-alcoholic fatty liver disease",
"nutrient",
"Alzheimer's Disease",
"Parkinson's disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient, inflammatory, energy storage that impacts atherosclerosis, pancreatitis, and thyroxine treatment. The molecule is a fat storage that impacts both obesity and metabolic syndrome. The molecule is a energy source and a membrane stabilizer, with effects on cancer and impacts on cardiovascular di... | CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCC(C)CC | [
"nutrient",
"Atherosclerosis",
"inflammatory",
"Energy storage",
"Pancreatitis",
"Thyroxine treatment",
"Obesity",
"Fat storage",
"Metabolic syndrome",
"Energy source",
"Cardiovascular disease",
"Membrane stabilizer",
"Cancer"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is both a pi3k inhibitor and a hdac inhibitor. | CC(C)C1NC(=O)CC2C=CCCSSCC(NC1=O)C(=O)NC(Cc1ccc3ccccc3c1)C(=O)NCC(=O)O2 | [
"pi3k inhibitor",
"hdac inhibitor"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a anti microbial. | COc1ccc2ncc(CF)c(C(O)CCC3(CO)CCN(CCOc4cc(F)cc(F)c4F)CC3)c2c1 | [
"anti microbial"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule has Distinctive odor. | CCOc1ccccc1 | [
"Odor_evaluation"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a organic electroluminescent material and belongs to the electroluminescent class of molecules. | Cc1ccnc(Nc2cccc3ccccc23)c1 | [
"electroluminescent",
"organic electroluminescent material"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a inflammatory and membrane stabilizer, affecting cancer, and impacting metabolic syndrome, obesity, and atherosclerosis. The molecule is a nutrient and energy source, and it impacts cardiovascular disease. The molecule is a fat storage and energy storage, belonging to the thyroxine treatment class of m... | CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"inflammatory",
"Metabolic syndrome",
"Obesity",
"Cancer",
"Atherosclerosis",
"Membrane stabilizer",
"Cardiovascular disease",
"nutrient",
"Energy source",
"Fat storage",
"Pancreatitis",
"Thyroxine treatment",
"Energy storage"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a food additive, membrane stabilizer, nutritional supplement, and nutrient, impacts diabetes mellitus type 2, and is smooth. The molecule is a emulsifier, a energy source, and a energy storage. The molecule is a surfactant that impacts non-alcoholic fatty liver disease, parkinson's disease, and alzheime... | CCCc1oc(CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCc2oc(CCC)c(C)c2C)c(C)c1C | [
"Smooth",
"food additive",
"Membrane stabilizer",
"Nutritional supplement",
"nutrient",
"Diabetes mellitus type 2",
"Emulsifier",
"Energy source",
"Energy storage",
"Non-alcoholic fatty liver disease",
"surfactant",
"Parkinson's disease",
"Alzheimer's Disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient. | CC(C)=CCc1c(O)ccc2c1OC1c3ccc(O)c(CC=C(C)C)c3OCC21 | [
"nutrient"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a beta-glucuronidase inhibitor, calcium channel blocker, nf-kappa-b inhibitor and belongs to the anti spasmodic class of molecules. The molecule is a mitogen-activated protein kinase inhibitor, a ec 1.14.14.14 (aromatase) inhibitor, a pesticide, and anti nociceptive. The molecule is a anti proliferant, ... | COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O)ccc1O.[Cl-] | [
"beta-glucuronidase inhibitor",
"calcium channel blocker",
"anti spasmodic",
"NF-kappa-B inhibitor",
"mitogen-activated protein kinase inhibitor",
"EC 1.14.14.14 (aromatase) inhibitor",
"anti nociceptive",
"pesticide",
"anti proliferant",
"anti polio",
"matrix-metalloproteinase-9 inhibitor",
"... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is anti inflammatory. | CCOC(=O)C=Cc1ccc2[nH]cc(CCc3ccccc3)c2c1 | [
"anti inflammatory"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts tangier disease and diabetic heart disease. The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts aging, barth syndrome, and non-alcoholic fatty liver disease. | CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Tangier disease",
"Diabetic heart disease",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Aging",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Non-alcoholic fatty liver disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts barth syndrome and tangier disease. The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts diabetic heart disease, non-alcoholic fatty liver disease, and aging. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC | [
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Aging"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts diabetic heart disease and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCC | [
"Barth syndrome",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Aging",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Tangier disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts diabetic heart disease, non-alcoholic fatty liver disease, and aging. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts barth syndrome and tangier disease. | CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC(C)C | [
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Aging",
"Cholesterol translocation",
"Barth syndrome",
"Tangier disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts barth syndrome and aging. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Barth syndrome",
"Aging",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Apoptosis"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a energy source that impacts celiac disease, inflammatory bowel disease, and heart failure. It impacts renal cell carcinoma, diabetes mellitus type 2, breast cancer, and cardiovascular disease. | CC=CCCCCCCC(O)C(=O)OC(CC(=O)[O-])C[N+](C)(C)C | [
"Celiac disease",
"Inflammatory bowel disease",
"Heart failure",
"Energy source",
"Renal cell carcinoma",
"Diabetes mellitus type 2",
"Breast cancer",
"Cardiovascular disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is anti histamine. | O=S(=O)(CC(O)CCCc1cnc[nH]1)NCc1ccccc1 | [
"anti histamine"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
It impacts cancer treatment. | CNC(=O)c1ncnc2c(C(C)C(C)CNc3cc(-c4ccc(F)nc4)ncn3)cccc12 | [
"cancer treatment"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts non-alcoholic fatty liver disease, tangier disease, and aging. The molecule is a stabilizing mitochondrial structure, apoptosis, proton trap for oxidative phosphorylation that impacts diabetic heart disease and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Aging",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Barth syndrome",
"Apoptosis",
"Proton trap for oxidative phosphorylation"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a liquid crystal and belongs to the ferroelectric class of molecules, impacting liquid crystal composition. | CCCCCCC(C)Oc1ccc(OC(=O)c2ccc(OCc3ccccc3)cc2)cc1 | [
"liquid crystal composition",
"liquid crystal",
"ferroelectric"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient that affects both breast cancer and cervical cancer, and also impacts ulcerative colitis and atherosclerosis. | CCCCC/C=C\C/C=C\C/C=C\C=C\C(=O)CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"nutrient",
"Ulcerative colitis",
"Breast cancer",
"Cervical cancer",
"Atherosclerosis"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease and aging. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, diabetic heart disease, and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCC(C)CC | [
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Aging",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Diabetic heart disease",
"Cholesterol translocation",
"Barth syndrome"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a energy source and fat storage, affecting cancer, and impacting thyroxine treatment, atherosclerosis, and pancreatitis. The molecule is a nutrient that impacts both cardiovascular disease and metabolic syndrome. The molecule is a inflammatory, a energy storage, and a membrane stabilizer, and it impacts... | CC(C)CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)C | [
"Energy source",
"Thyroxine treatment",
"Atherosclerosis",
"Cancer",
"Fat storage",
"Pancreatitis",
"Cardiovascular disease",
"Metabolic syndrome",
"nutrient",
"inflammatory",
"Obesity",
"Energy storage",
"Membrane stabilizer"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a anti viral. | CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C2OC(C)(C)OC12)Oc1ccc2c(c1)CCCC2 | [
"anti viral"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutrient and belongs to the thyroxine treatment class of molecules, impacting atherosclerosis. The molecule is a fat storage that impacts cardiovascular disease, metabolic syndrome, and pancreatitis. | CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | [
"Atherosclerosis",
"nutrient",
"Thyroxine treatment",
"Cardiovascular disease",
"Metabolic syndrome",
"Fat storage",
"Pancreatitis"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a adrenergic agent, beta-adrenergic antagonist, nutrient, belonging to the anti oxidant class of molecules, with a Sharp, garlic flavor and a Garlic odor. | C=CCSSCC=C | [
"taste_evaluation",
"adrenergic agent",
"beta-adrenergic antagonist",
"nutrient",
"Odor_evaluation",
"anti oxidant"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a cysteine protease inhibitor, cathepsin s inhibitor, and cathepsin inhibitor, belonging to the anti inflammatory class of molecules, and is both atherosclerosis treatment and metabolic disease treatment. | Cc1cc(-c2ccc(S(=O)(=O)C3CC(C(=O)O)N(C(=O)C4(C(F)(F)F)CC4)C3)c(C(F)(F)F)c2)ccn1 | [
"cysteine protease inhibitor",
"cathepsin s inhibitor",
"cathepsin inhibitor",
"anti inflammatory",
"atherosclerosis treatment",
"metabolic disease treatment"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, tangier disease, and aging. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, apoptosis that impacts diabetic heart disease and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC | [
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Aging",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Diabetic heart disease",
"Barth syndrome"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a thyroxine treatment, energy source, fat storage that impacts metabolic syndrome, pancreatitis, and obesity. The molecule is a nutrient and membrane stabilizer, and it impacts atherosclerosis. The molecule is a energy storage and a inflammatory, with effects on cancer and impacts on cardiovascular dise... | CCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C | [
"Metabolic syndrome",
"Pancreatitis",
"Thyroxine treatment",
"Energy source",
"Obesity",
"Fat storage",
"nutrient",
"Membrane stabilizer",
"Atherosclerosis",
"Cancer",
"Cardiovascular disease",
"Energy storage",
"inflammatory"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a convulsant and dopamine uptake inhibitor, belonging to both the anti spasmodic and pyrogenic classes of molecules. The molecule is a central nervous system stimulant, hyperthermic, fungicide, analgesic, and pesticide. | NC(N)=NCCS(=O)(=O)O | [
"convulsant",
"dopamine uptake inhibitor",
"anti spasmodic",
"pyrogenic",
"central nervous system stimulant",
"hyperthermic",
"fungicide",
"analgesic",
"pesticide"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a tyrosine kinase inhibitor, a anti tumor, and anti tumour. | CC1CN(c2cc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CCN1C(=O)CN | [
"tyrosine kinase inhibitor",
"anti tumor",
"anti tumour"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts non-alcoholic fatty liver disease and barth syndrome. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts tangier disease, diabetic heart disease, and aging. | CCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Tangier disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Aging"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
It impacts cardiovascular disease, metabolic syndrome, and pancreatitis. The molecule is a nutrient and a fat storage, it impacts atherosclerosis, and is thyroxine treatment. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCC/C=C\CCCCCC)COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC | [
"Cardiovascular disease",
"Metabolic syndrome",
"Pancreatitis",
"nutrient",
"Thyroxine treatment",
"Atherosclerosis",
"Fat storage"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The organic electroluminescent compound class molecule influences improved driving voltage and is electroluminescent. | c1ccc(N(c2cc(N(c3ccccc3)c3cc4ccccc4c4ccccc34)c3ccc4ccccc4c3c2)c2cc3ccccc3c3ccccc23)cc1 | [
"electroluminescent",
"organic electroluminescent compound",
"improved driving voltage"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a anti tumor agent and a mtor inhibitor, belonging to the anti tumor class of molecules. | COC1CCC(Cn2c(=O)[nH]c3ncc(-c4cnc5[nH]cc(Cl)c5c4C)cc32)OC1 | [
"anti tumor",
"anti tumor agent",
"mtor inhibitor"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a mmp13 inhibitor. | CC(C)(C)OC(=O)Oc1cccc(-c2ccc(C(=O)O)c(Nc3cccc(O)c3)c2)c1 | [
"mmp13 inhibitor"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
It impacts insulin resistance, neurodegenerative disease, and diabetes mellitus. | CCCCC/C=C\C/C=C\C/C=C\CC(O)C(O)CCCC(=O)N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC | [
"Insulin resistance",
"Neurodegenerative disease",
"Diabetes mellitus"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a cancer treatment. | Nc1ccc(F)cc1-c1ccc(C2=NNC(=O)CC2)cc1F | [
"cancer treatment"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a energy source and a fat storage that impacts cardiovascular disease, thyroxine treatment, obesity, and pancreatitis. The molecule is a nutrient and membrane stabilizer, and it impacts cancer. The molecule is a inflammatory and a energy storage, impacting both atherosclerosis and metabolic syndrome. | CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC | [
"Cardiovascular disease",
"Thyroxine treatment",
"Energy source",
"Obesity",
"Fat storage",
"Pancreatitis",
"Cancer",
"nutrient",
"Membrane stabilizer",
"inflammatory",
"Atherosclerosis",
"Energy storage",
"Metabolic syndrome"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts diabetic heart disease and aging. The molecule is a apoptosis and a cholesterol translocation that impacts non-alcoholic fatty liver disease, barth syndrome, and tangier disease. | CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | [
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Aging",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Apoptosis",
"Tangier disease",
"Cholesterol translocation"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, cholesterol translocation that impacts barth syndrome. The molecule is a apoptosis that impacts non-alcoholic fatty liver disease, aging, tangier disease, and diabetic heart disease. | CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C | [
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Barth syndrome",
"Non-alcoholic fatty liver disease",
"Aging",
"Apoptosis",
"Tangier disease",
"Diabetic heart disease"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a apoptosis, a nutritional supplement, and a food additive, and it impacts non-alcoholic fatty liver disease. The molecule is a emulsifier, a energy storage, and a stabilizing mitochondrial structure, it impacts tangier disease and is smooth. The molecule is a membrane stabilizer, a energy source, and a... | CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Apoptosis",
"Nutritional supplement",
"Non-alcoholic fatty liver disease",
"food additive",
"Tangier disease",
"Emulsifier",
"Smooth",
"Energy storage",
"Stabilizing mitochondrial structure",
"Membrane stabilizer",
"Energy source",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a anti bacterial drug. | CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1 | [
"anti bacterial drug"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is fresh, sweet, orange peel, and fruity. | CCCCCc1cccs1 | [
"fresh",
"sweet",
"orange peel",
"fruity"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a spice that is woody and wood. | CC1C=Cc2nccnc21 | [
"woody",
"wood",
"spice"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is pungent, sweet, and pharmaceutical. The molecule is a fragrance and a flavor, as well as green and aldehydic. The molecule is fresh, citrus, fatty, and soapy. The molecule is laundry, waxy, oil, and floral. | CCCCCC(O)CCC(O)C(O)CCCCCCCC(=O)O | [
"pungent",
"sweet",
"Pharmaceutical",
"green",
"aldehydic",
"fragrance",
"flavor",
"fresh",
"citrus",
"fatty",
"soapy",
"laundry",
"waxy",
"oil",
"floral"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a fat storage, energy source, membrane stabilizer that impacts obesity, cancer, and metabolic syndrome. The molecule is a energy storage that impacts both atherosclerosis and pancreatitis. The molecule is a nutrient and a inflammatory, impacting both cardiovascular disease and thyroxine treatment. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Fat storage",
"Obesity",
"Cancer",
"Energy source",
"Membrane stabilizer",
"Metabolic syndrome",
"Energy storage",
"Atherosclerosis",
"Pancreatitis",
"Cardiovascular disease",
"nutrient",
"inflammatory",
"Thyroxine treatment"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a organic light-emitting device. | c1ccc(-n2c3cc4c(cc3c3cc5c6cc7c(cc6n(-c6ccccc6)c5cc32)CC7)CC4)cc1 | [
"organic light-emitting device"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a nutritional supplement, a emulsifier, and a energy source, and it impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation, a energy storage, and a food additive, it impacts aging and is smooth. The molecule is a stabilizing mitochondrial structure, a apoptosis, and a stabil... | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Nutritional supplement",
"Emulsifier",
"Barth syndrome",
"Energy source",
"Proton trap for oxidative phosphorylation",
"Energy storage",
"Aging",
"Smooth",
"food additive",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Diabetic h... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
This molecule is a member of the electroluminescent class and influences organic electroluminescence. | c1ccc(-c2ccc(-c3nc4ccccc4n3-c3ccc(-c4ccc(-c5ccc6oc7cc8c(cc7c6c5)oc5ccccc58)cc4)cc3)cc2)cc1 | [
"electroluminescent",
"organic electroluminescence"
] | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
The molecule is a energy storage and a cholesterol translocation, impacting both non-alcoholic fatty liver disease and aging. The molecule is a surfactant, a stabilizing cytochrome oxidase, and a emulsifier, it impacts diabetic heart disease and is smooth. The molecule is a food additive and a stabilizing mitochondrial... | CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C | [
"Energy storage",
"Non-alcoholic fatty liver disease",
"Aging",
"Cholesterol translocation",
"surfactant",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Emulsifier",
"Smooth",
"food additive",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Barth syndrome",
"Proto... | {
"Actives": null,
"Approval Date": null,
"Brand Name": null,
"Indication": null,
"PubChem CIDs": null
} |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.